Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension

被引：20
|
作者：
Anthi, Anastasia [1 ,2 ]
Tsangaris, Iraklis [1 ,2 ]
Hamodraka, Eftichia S. [3 ]
Lekakis, John [2 ,3 ]
Armaganidis, Apostolos [1 ,2 ]
Orfanos, Stylianos E. [1 ,2 ]
机构：
[1] Univ Athens, Sch Med, Dept Crit Care 2, Attikon Gen Hosp, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Pulm Hypertens Clin, Attikon Gen Hosp, GR-11527 Athens, Greece
[3] Univ Athens, Sch Med, Dept Cardiol 2, Attikon Gen Hosp, GR-11527 Athens, Greece
来源：
BLOOD | 2012年 / 120卷 / 07期
关键词：
SICKLE-CELL-DISEASE; SILDENAFIL;
D O I：
10.1182/blood-2012-04-422568
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1531 / 1532
页数：4
相关论文
共 50 条
  • [41] Risk factors for pulmonary hypertension in patients with β thalassemia intermedia
    Karimi, Mehran
    Musallam, Khaled M.
    Cappellini, Maria Domenica
    Daar, Shahina
    El-Beshlawy, Amal
    Belhoul, Khawla
    Saned, Mohamed-SalahEldin
    Temraz, Sally
    Koussa, Suzanne
    Taher, Ali T.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2011, 22 (06) : 607 - 610
  • [42] Risk factors for pulmonary hypertension in patients with thalassemia intermedia
    Amoozgar, Hamid
    Farhani, Nahal
    Karimi, Mehran
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (06) : 549 - 551
  • [43] Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia
    Karimi, Mehran
    Borzouee, Mohammad
    Mehrabani, Alireza
    Cohan, Nader
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (03) : 213 - 218
  • [44] The improvement of pulmonary artery pressure after bosentan therapy in patients with β-thalassemia and Doppler-defined pulmonary arterial hypertension
    Karami, Hossein
    Darvishi-Khezri, Hadi
    Kosaryan, Mehrnoush
    Akbarzadeh, Rosetta
    Dabirian, Mojdeh
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2019, 12 : 1 - 7
  • [45] Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension
    Ilsar, R.
    Levitt, J.
    Ng, M. K. C.
    Kritharides, L.
    Adams, M. R.
    Celermajer, D. S.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (06) : 1483 - 1485
  • [46] Long term treatment with bosentan for pulmonary arterial hypertension related to systemic sclerosis
    Cozzi, F
    Montisci, R
    Marotta, H
    Bobbo, F
    Favaro, M
    Tiso, F
    Ciprian, L
    Iliceto, S
    Todesco, S
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 297 - 297
  • [47] Long-term bosentan treatment in children with pulmonary arterial hypertension - Reply
    Rosenzweig, EB
    Ivy, DD
    Widlitz, A
    Doran, A
    Claussen, LR
    Yung, D
    Abman, SH
    Barst, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) : 1915 - 1915
  • [48] Bosentan for Treatment of Pediatric Idiopathic Pulmonary Arterial Hypertension: State-of-the-Art
    Wang, Yuchen
    Chen, Selena
    Du, Junbao
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [49] Pulmonary arterial hypertension treatment with bosentan in pediatric patients with congenital heart disease
    Romero Jimenez, Rosa M.
    Garcia Sanchez, Raquel
    Gimenez Manzorro, Alvaro
    Martinez Fernandez-Llamazares, Cecilia
    Sanjurjo Saez, Maria
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 347 - 347
  • [50] Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan
    Beghetti, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 16 - 24
12345